WOLVERINE ASSET MANAGEMENT LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 116 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$01090.0%0.00%
Q3 2019$01090.0%0.00%
Q2 2019$0
-100.0%
1090.0%0.00%
Q1 2019$1,0001090.0%0.00%
Q4 2018$0
-100.0%
109
-98.7%
0.00%
-100.0%
Q1 2018$139,000
-15.2%
8,7000.0%0.00%0.0%
Q4 2017$164,000
-43.6%
8,700
-58.0%
0.00%
-33.3%
Q3 2017$291,00020,700
+20600.0%
0.00%
Q2 2017$0
-100.0%
100
-99.5%
0.00%
-100.0%
Q1 2017$137,000
-7.4%
21,100
-37.0%
0.00%0.0%
Q4 2016$148,000
+82.7%
33,500
+91.4%
0.00%
+100.0%
Q3 2016$81,000
-89.7%
17,500
-85.3%
0.00%
-91.7%
Q2 2016$783,000
+2075.0%
119,200
+8177.8%
0.01%
+1100.0%
Q1 2016$36,000
+3500.0%
1,440
+853.6%
0.00%
Q4 2015$1,000151
+51.0%
0.00%
Q2 2015$0
-100.0%
100
-94.2%
0.00%
-100.0%
Q1 2015$29,000
+314.3%
1,725
+70.1%
0.00%
Q4 2014$7,000
-66.7%
1,0140.0%0.00%
Q3 2014$21,000
+425.0%
1,014
+8350.0%
0.00%
Q2 2014$4,000
-91.7%
12
-99.3%
0.00%
-100.0%
Q1 2014$48,000
-27.3%
1,608
+3.1%
0.00%0.0%
Q4 2013$66,000
-35.9%
1,560
-86.9%
0.00%
-50.0%
Q3 2013$103,000
+10.8%
11,9080.0%0.00%0.0%
Q2 2013$93,00011,9080.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders